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Quantitative Trait Loci Affecting Liver Fat
Content in Mice
Olga Minkina,*,1 James M. Cheverud,* Gloria Fawcett,*,2 Clay F. Semenkovich,†
and Jane P. Kenney-Hunt*,3,4
*Department of Anatomy and Neurobiology and †Department of Medicine, Washington University School of Medicine,
St. Louis, Missouri 63110
ABSTRACT Nonalcoholic fatty liver disease, a condition in which excess fat accumulates in the liver, is
strongly associated with the metabolic syndrome, including obesity and other related conditions. This
disease has the potential to progress from steatosis to steatohepatitis, ﬁbrosis, and cirrhosis. The recent
increase in the prevalence of the metabolic syndrome is largely driven by changes in diet and activity levels.
Individual variation in the response to this obesogenic environment, however, is attributable in part to
genetic variation between individuals, but very few mammalian genetic loci have been identiﬁed with
effects on fat accumulation in the liver. To study the genetic basis for variation in liver fat content in
response to dietary fat, liver fat proportion was determined using quantitative magnetic resonance imaging
in 478 mice from 16 LG/J X SM/J recombinant inbred strains fed either a high-fat (42% kcal from fat) or low-
fat (15% kcal from fat) diet. An analysis of variance conﬁrmed that there is a genetic basis for variation in liver
fat content within the population with signiﬁcant effects of sex and diet. Three quantitative trail loci that









Components of the metabolic syndrome, including obesity, type 2
diabetes, insulin resistance, and hyperdyslipidemia, are very frequently
accompanied by nonalcoholic fatty liver disease (NAFLD) (Del Gaudio
et al. 2002; Marchesini et al. 2003; Adams et al. 2005; Fabbrini et al.
2009; Bugianesi et al. 2010). NAFLD describes a range of conditions
varying in severity from steatosis to nonalcoholic steatohepatitis, to
ﬁbrosis and ﬁnally cirrhosis (James and Day 1998). Even in the less
severe manifestations, such as steatosis, NAFLD has important con-
sequences for health and metabolism. In several recent studies authors
have shown that the accumulation of fat in the visceral cavity, and
particularly in the liver, is primarily responsible for the negative met-
abolic effects of obesity (Stefan and Häring 2011).
Lipid accumulation in the liver is strongly correlated with insulin
resistance, but it is currently unclear whether a causal relationship
between insulin resistance and lipid accumulation in the liver exists
(Fabbrini et al. 2009). A study of familial hypobetalipoproteinemia, in
which a mutation impairs the ability to export intrahepatic triglycer-
ides (IHTG), revealed that patients have similar levels of insulin sen-
sitivity as patients with normal IHTG (Amaro et al. 2010). In addition,
although a single-nucleotide polymorphism (SNP) in human PNPLA3
is signiﬁcantly correlated with increased hepatic fat, it is not correlated
with insulin resistance (Romeo et al. 2008). Steatosis can also occur
without insulin resistance in mice (Grefhorst et al. 2005; Minehira
et al. 2008).
The relationship between lipid accumulation and body weight is
similarly complex. Although NAFLD rates increase with increasing
body mass index (Ruhl and Everhart 2003), not all obese subjects
suffer from metabolic abnormalities. Conversely, some subjects with
normal body mass index have these abnormalities (Wildman et al.
2008). Several studies argue that visceral adipose tissue is the most
accurate predictor of the metabolic syndrome (Carey et al. 1996;
Atzmon et al. 2002; Wajchenberg et al. 2002). Fabbrini et al.
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(2009), however, found that although visceral adipose tissue and
IHTG measurements are correlated, IHTG content is the better pre-
dictor of metabolic abnormalities associated with obesity. Although
even small amounts of weight loss in obese patients can reverse stea-
tosis and reduce hepatic insulin resistance (Petersen et al. 2005;
Adams and Angulo 2006; Klein et al. 2006; Larson-Meyer et al.
2008; Kirk et al. 2009), much remains unknown about the relation-
ships between these metabolic dysfunctions or why some cases of
steatosis progress to the more severe stages, whereas others do not.
The recent and rapid worldwide increase in metabolic syndrome
and related conditions is thought to be attributable to changes in diet
and activity level, resulting in an imbalance between energy intake and
expenditure (Yanovski and Yanovski 1999; Heymsﬁeld 2009). Indi-
vidual response to this obesogenic environment is inﬂuenced by ge-
netic variation between individuals (Musani et al. 2008). Metabolic
syndrome and related conditions, including NAFLD, are complex
traits, resulting from the expression of many alleles of small effect
interacting with each other and with the dietary environment. Eth-
nicity and sex are known to play a role in the prevalence of NAFLD
(Browning et al. 2004), suggesting complex interactions between
genes, sex, and diet. To date, only a few genetic loci have been iden-
tiﬁed with effects on hepatic fat content in mammals (Rangnekar et al.
2006; Itoi-Babaya et al. 2007; Kumazawa et al. 2007; Romeo et al.
2008, Millward et al. 2009). Further understanding of the genetic
factors that interact with the environment to contribute to the pathol-
ogy of NAFLD will help to identify the physiologic pathways regulat-
ing lipid accumulation in the liver and aid in understanding
the relationships between fatty liver disease and other obesity- and
diabetes-related traits. Identiﬁcation of quantitative trait loci (QTL)
for hepatic fat accumulation in a nonmutant murine model of meta-
bolic syndrome, such as the LG/J X SM/J intercross and derived
strains (Ehrich et al. 2003; Cheverud et al. 2004a,b), can contribute
substantially to our understanding of the genetics of NAFLD.
This experiment examined the genetic architecture of variation in
lipid accumulation in the liver in response to dietary fat in 16
recombinant inbred mouse strains (RI strains) of the LG/J X SM/J
intercross. Interactions between genetic background (strain), sex, and
diet were identiﬁed. QTL analysis was performed to map QTL that
contribute to liver fat content.
MATERIALS AND METHODS
The LG/J and SM/J inbred mouse strains (Jackson Laboratories, Bar
Harbor, ME) were derived independently more than 60 years ago
(Goodale 1938; Goodale 1941; MacArthur 1944). Selection for large
and small body size at 60 days of age resulted in the creation of the
LG/J and SM/J strains, respectively, with a mean body weight differ-
ence of 24 g at this age (Chai 1956; Chai 1957). Analysis of the genetic
architecture of the body size of LG/J and SM/J strains revealed that the
size differences between the two strains are attributable to the inter-
action of many genes of small effect (Chai 1956). Sixteen recombinant
inbred strains (RI strains) obtained from the LG/J X SM/J F2 inter-
cross were used in this analysis (Hrbek et al. 2006).
The mice were housed in a facility that maintained 12-hour light/
dark cycles and a temperature of 21. All procedures followed the
guidelines for the care of laboratory animals at Washington University
School of Medicine (Assurance #A-3381-01). Sires and dams from
each of the 16 RI strains and LG/J and SM/J were fed a standard
mouse chow (PicoLab Rodent Chow 20, #5053). Male and female
offspring were weaned at 3 weeks of age, at which point they were
separated into single-sex cages of no more than ﬁve animals. The mice
were then fed ad libitum either a high-fat (42%, Harlan Teklad
#TD88137) or low-fat (15%, custom, formerly Research Diets
#D12284) diet. The diets are nearly isocaloric (Table 1). At 20 weeks
of age, the mice were fasted for 4 hr in the morning, killed, and
necropsied. At necropsy, the masses of the whole carcass, liver, fat
pads (mesenteric, inguinal, reproductive, and kidney), heart, spleen,
and kidney were collected. Blood plasma was obtained by cardiac
puncture and analyzed for free fatty acids, cholesterol, triglycerides,
leptin, and insulin content. Liver samples were stored at 280.
Liver samples were thawed and placed into tubes that were
inserted into an EchoMRI 3-in-1 instrument (Echo Medical Systems,
Houston, TX) to measure liver fat content. The EchoMRI 3-in-1 is
a nuclear magnetic resonance instrument that distinguishes between
fat and lean content within tissues. Fat and lean content of each liver
sample was measured in milligrams at the highest precision.
Quantitative magnetic resonance imaging (QMR) has a greater
precision in determining fat and lean mass than dual-energy X-ray
n Table 1 Components of high-fat (HF) and low-fat (LF) diets
HF Diet LF Diet
Energy from fat, % 42 15
Casein, g/kg 195 197
Sugars, g/kg 341 307
Corn starch, g/kg 150 313
Cellulose, g/kg 50 50
Corn oil, g/kg 2 58
Hydrogenated coconut oil, g/kg 2 7
Anhydrous milk fat, g/kg 210 2
Cholesterol, g/kg 1.5 2
Kilojoules per gram 18.95 16.99
Figure 1 Strain mean residuals of liver fat mass regressed onto lean
mass (“liver fattiness”) in male (M) and female (F) mice fed a high-fat
(HF) and a low-fat (LF) diet. Numbers and LG, SM represent strains.
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absorptiometry or chemical carcass analysis in studies of whole-body
composition in mammals, and although slightly biased toward greater
fat levels, is highly correlated to these other methods (Taicher et al.
2003; Tinsley et al. 2004; Napolitano et al. 2008; Johnson et al. 2009;
Jones et al. 2009; Gallagher et al. 2010; Nixon et al. 2010). Because all
of our data were collected with the same QMR protocol on the same
machine, this bias does not have any effect on the variance among
individuals or strains, which is the object of our study.
Additional data were collected to determine whether QMR data
from these samples demonstrates high repeatability, high heritability,
and high correlation to biochemical analysis. Holding tissues at 280,
thawing, and then measuring lipid levels with nuclear magnetic reso-
nance may alter liver fat proportions relative to measures on fresh
tissue. However, all specimens were treated the same, and it is the
relative values, not the absolute ones, that are important for quanti-
tative genetic analysis. Liver samples from a subset of high-fat fed
males from this study (n = 35) were analyzed using chemical methods
to determine hepatic triglyceride levels. QMR and chemical results
were highly correlated both in phenotype (r = 0.69, P = 1 · 1026)
and in genotype (r = 0.73). Although QMR data showed a bias to
greater values than results from the chemical analysis, the QMR data
also had a greater heritability (H2 = 0.88), and data from genetically
identical individuals were more similar to one another in QMR anal-
ysis than in chemical analysis. The higher heritability determined by
QMR may be attributable in part to the very high precision of this
method (Taicher et al. 2003; Tinsley et al. 2004). In an additional
study of 20 archived liver samples from an outbred population, re-
peatability of fat mass and lean mass between QMR trials was excel-
lent (r2 . 0.99). In contrast, when submitted to chemical analysis
within 48 hr of necropsy, repeatability between two different ~0.10
g samples from the same liver was somewhat lower (r2 = 0.77, n = 16).
Although the experiment was designed to obtain 64 sex-diet-strain
cohorts each containing eight mice, breeding success varied among
strains, resulting in unequal numbers of animals in each cohort. The
average number of mice in each sex-diet-strain cohort was seven. A
total of 479 mice, which included 425 RI strain, 25 LG/J, and 29 SM/J
mice, were analyzed in this study (supporting information, Table S1
and Table S2).
DNA was extracted from livers using QIAGEN DNeasy Blood and
Tissue Kits. All RI strains, SM/J, and LG/J were genotyped at 1436
SNP loci using Illumina Golden Gate technology, 512 of which were
nonredundant and informative (Table S3). These loci were distributed
as evenly as possible throughout the genome, on all 19 autosomes and
the X chromosome. Bonferroni-adjusted chromosome-wide and ge-
nome-wide 5% signiﬁcance thresholds for QTL analysis were calcu-
lated using the method of Li and Ji (2005).
Statistical analysis
The mass of liver analyzed for fat and lean content was not
standardized between samples and, of course, different animals have
different-sized livers. Thus, statistical analysis, including QTL analysis,
was performed on the residuals of liver fat mass regressed onto lean
mass (“liver fattiness”), except where noted.
A three-way mixed model analysis of variance with ﬁxed-effects
sex and diet and random effect strain was used to calculate variance
and broad-sense heritability:
Yijk ¼ mþ Sexi þ Dietj þ Straink þ

Sexi ·Dietj
þ ðSexi · StrainkÞ
þ Dietj · Straink
þ Sexi ·Dietj · Straink
þ eijk
Variance caused by the strain (s2str) represents the total genetic
variance among individuals:
s2str ¼ ðMSstr2MSrÞ=n
where MS is the mean square, r is the residual, and n is the total
number of animals per strain. An adjusted n was used to account for
n Table 2 Genetic correlations (r) between liver fattiness and




Liver weight, g 0.61
Cholesterol, mg/dL 0.44
Body weight at necropsy, g 0.28
Mesenteric fat pad weight, g 0.26
Free fatty acids, mmol/L 0
Inguinal fat pad weight, g 20.01
Total fat pad weight, g 20.02
Reproductive fat pad weight, g 20.07
Renal fat pad weight, g 20.15
Heart weight, g 20.51
Triglyceride, mg/dL 20.32
Kidneys weight, g 20.54
Figure 2 Strain mean percent increase in liver fat
content (fat to total mass ratio) in male (M) and female
(F) mice fed a high-fat diet over male and female mice
fed a low-fat diet. Numbers and LG, SM represent
strains.
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the variation in sample size (see Materials and Methods section)
according to the method of Sokal and Rohlf (1995). Variance caused
by the two-way interactions of sex and strain and diet and strain and
the three-way interaction of sex, diet, and strain also were calculated




where n is to the number of animals per sex-strain, diet-strain, or
sex-diet-strain cohort. Broad-sense heritabilities (H2), the ratio of
genetic to phenotypic variance, were calculated for liver fattiness





Genetic correlations (between-strain correlations) between liver
fattiness and other dietary obesity traits in this population (Cheverud
et al. 2004b) were determined using Pearson product moment
correlation.
Mean liver fattiness was calculated for each strain-sex-diet cohort,
and these values were used as the individual trait values in QTL
analysis (n = 72). The mean can be used as all individuals within
a strain are genetically identical. QTL analysis was performed using
a maximum likelihood approach with the mixed model procedure in
SAS 9.2 (SAS Institute, Cary, NC). The model includes the effects of
sex, diet, genotype, and their interactions:








þ Sexi ·Dietj ·Genotypek
þ eijkl
Yijkl represents the mean phenotype of a strain-sex-diet cohort of
strain l with sex i, diet j, and genotype k with constant m and residual
eijkl. Sex and diet were ﬁxed effects.
Sex-by-genotype and diet-by-genotype interactions were common,
so analyses were also performed on the sex, diet, and sex-diet cohorts
separately. QTL were located at SNP positions at which the LOD score
(log10(1/p)) was greater than the chromosome-wide 5% signiﬁcance
threshold. Ninety-ﬁve percent support intervals for each QTL in-
cluded the one-LOD drop from the peak LOD score by convention.
RESULTS
The effect of diet on liver fattiness, deﬁned as the residuals of fat
mass regressed onto lean mass, was highly signiﬁcant (P = 1.9 ·
1025). The effect of sex on liver fattiness was also statistically
signiﬁcant (P = 1 · 1023), with females having a fattier liver than
males in nine of the 16 RI strains. The effect of strain, the genetic
effect, was highly signiﬁcant for liver fattiness (P = 1.3 · 10215)
within the population (Figure 1).
A signiﬁcant strain-by-sex interaction (P = 6.7 · 1024) indicated
that there was a genetic basis for sexual dimorphism in liver fattiness.
The diet-by-sex interaction was also signiﬁcant (P = 0.017) within this
population. Most interestingly, a highly signiﬁcant strain-by-diet in-
teraction (P = 8.2 · 1026) supports a genetic basis for variation in liver
fattiness in response to dietary fat among the strains. The three-way
interaction between sex, diet, and strain, which indicates whether
there is a genetic basis for sexual dimorphism in response to dietary
fat, was not quite signiﬁcant (P = 0.065).
The genetic correlation between liver fattiness in the high- and
low-fat diet environments was 0.61, indicating that 37% of the genetic
variance in liver fattiness is shared between the low- and high-fat diets.
Thus, most genetic effects on liver fattiness are speciﬁc to either the
n Table 3 Basic statistics for liver fat content
All HF ♀ LF ♀ HF ♂ LF ♂
Average 0.27 0.31 0.24 0.29 0.23
SD 0.08 0.08 0.06 0.1 0.06
N 479 104 127 129 119
Means and SD for liver fat content, deﬁned as the ratio of fat to total mass, for all
individuals and sex-diet cohorts individually. N, number of individuals per
cohort; HF, high-fat diet; ♀, female; LF, low-fat diet, ♂, male. See Table S1 for
statistics of individual strains
Figure 3 LOD plots of each of the three QTL: (A) NAFLD4, (B)
NAFLD11, and (C) NAFLD14. The horizontal line indicates the 5%
chromosome-wide signiﬁcance threshold.
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low- or high-fat diet. Genetic correlations between liver fattiness and
other dietary obesity- and diabetes-related traits (Cheverud et al.
2004b) were also calculated (Table 2). As expected, the genetic corre-
lation between liver fattiness and liver weight (r = 0.61) is relatively
high. Liver fattiness is also strongly genetically correlated with serum
insulin (r = 0.63) and serum leptin (r = 0.64) levels and moderately
correlated with serum cholesterol level (r = 0.44). Liver fattiness is
negatively correlated with heart (r = 20.51) and kidney (r = 20.54)
weight. Liver fattiness is not signiﬁcantly correlated with serum free
fatty acid levels, serum triglycerides, body weight at necropsy, or any
of the four fat pad weights (reproductive, renal, mesenteric, and
inguinal).
Broad-sense heritability (H2) of liver fattiness was 22%. H2 within
sex-diet cohorts varied from 53% in high-fat fed males to 11% in low-
fat fed females. H2 in low-fat males and high-fat females was 20% and
31%, respectively. H2 of dietary response (strain-by-diet) was 17% and
H2 of sexual dimorphism (sex-by-strain) was 12%. The three-way sex-
diet-strain H2 was 9%, indicating that heritable genetic variation for
sexual dimorphism in response to dietary fat is limited.
The aforementioned statistics reveal that the strains differed
signiﬁcantly in the response to the high-fat diet. We characterized
the individual strains for liver fat levels and response to a high-fat diet
by using percent liver fat rather than liver fattiness for didactic
purposes. Among the 16 RI strains, LG/J, and SM/J, the ratio of liver
fat mass to total mass signiﬁcantly (P# 0.05) increased in response to
a high-fat diet in both males and females in six of the 18 strains
(LGXSM-10, 22, 35, 48, SM/J, LG/J; Figure 2). The most extreme liver
fat increase from low-fat to high-fat diet was more than120% in the
SM/J strain. The RI strain, with the greatest increase in liver fat in
response to a high-fat diet, increased 98% in males and 65% in females
(LGXSM-48). Liver fat content increased signiﬁcantly only in females
in three strains (LGXSM-4, 18, 33). The livers of eight strains were not
signiﬁcantly responsive to the high-fat diet (LGXSM-5, 15, 19, 20, 23,
38, 45, and 46). The signiﬁcance of dietary response in LGXSM-31
females was not calculated because this strain included only one low-
fat fed female; dietary response is not signiﬁcant in males of this strain.
Mean liver fat mass to total mass ratios, standard deviations, and
sample sizes for each sex-diet cohort are listed in Table 3.
Quantitative trait loci
Three QTL that contribute to variation in liver fattiness within the
population were identiﬁed (Figure 3, Table 4). These QTL were
named NAFLD4, NAFLD11, and NAFLD14, with the number indicat-
ing their chromosomal location. Genomic regions within these loci
contain between 64 and 288 genes. Two of the three QTL were sex-
speciﬁc, with NAFLD4 contributing to variation in liver fattiness only
in females and NAFLD14 contributing to variation in liver fattiness
only in high fat-fed males.
Comparison with previously identiﬁed dietary obesity and di-
abetes-related QTL revealed QTL with effects on liver weight in the
NAFLD4 and NAFLD11 support interval (Cheverud et al. 2004a) and
for serum insulin and serum glucose within NAFLD14 (Table 4). An
analysis of additive effects was performed to determine whether the
LG/J or SM/J allele at each QTL leads to a greater liver fattiness value.
The SM/J allele leads to greater liver fattiness than the LG/J allele at all
three QTL.
DISCUSSION
The identiﬁcation of three QTL that contribute to variation in liver
fattiness in the mouse population conﬁrms that the LG/J X SM/J
intercross is not only a model for obesity as a complex disease (Ehrich
et al. 2003; Cheverud et al. 2004a,b), but also has potential as a model
for the study of NAFLD. Some RI strains respond more strongly to
a high-fat diet than others, indicating that these strains could poten-
tially serve as good models of diet-induced NAFLD. Figure 2 provides
the percent increase in ratio of liver fat mass to total mass in males
and females fed a high-fat diet over males and females fed a low-fat
diet by strain. LGXSM-48 responds most strongly to the high-fat diet,
with liver fat content in males increasing by 98%. Interestingly, how-
ever, although the ratio of liver fat mass to total mass increases by 65%
in LGXSM-48 females fed a high-fat diet, mice within this cohort have
previously been shown to have insulin and basal glucose levels within
the normal range. Males of this strain are hyperinsulemic when fed
a high-fat diet (Cheverud et al. 2004b).
The RI strains exhibit varying amounts of sexual dimorphism in
liver fat in response to the high-fat diet. In LGXSM-33, the ratio of
liver fat mass to total mass increased by 70% in females fed a high-fat
diet but only by 17% in males. In LGXSM-33 females, basal glucose
and insulin levels remained within the normal range, even in females
fed a high-fat diet. Males of this strain, however, are both hyper-
insulemic and hyperglycemic regardless of their diet and may be
considered diabetic (Cheverud et al. 2004b). LGXSM-20 and LGXSM-
46 are also of interest as strains that fail to increase liver fat on a high-
fat diet.
That liver fattiness was not correlated with body weight at
necropsy nor the fat depot weights consistent with a study by Fabbrini
et al. (2009), in which they showed that an increase in visceral adipose
tissue is not a good marker for metabolic dysfunction associated with
obesity. Fat within the liver correlates with decreased insulin sensitiv-
ity and may be a better marker for dysfunction. This ﬁnding is con-
sistent with the high correlation between serum insulin and liver
fattiness (r2 = 0.63).
Because so little is known about the role of genetic variants in
NAFLD, this study adds substantial information about NAFLD
genetic architecture in addition to the identiﬁcation of QTL. Because
both LG/J and SM/J strains responded with increased liver fattiness on
the high-fat diet whereas most of their RI strains responded less
extremely, it is possible that dominance and epistasis play an
important role in the genetic architecture of this trait. This study
cannot address dominance or dominance forms of epistasis by design
and contains inadequate strain numbers for an evaluation of epistasis.
In the future, liver fat will be quantiﬁed in a larger population of F34
n Table 4 QTL for liver fattiness
QTL SNP CI LOD a No. Genes Cohort Other QTL in Interval
NAFLD4 rs13477769 70.2-98.5 3.01 1.21 182 Female Liver weight
NAFLD11 rs6180460 98.9-106.2 3.04 0.68 288 All Liver weight
NAFLD14 rs13482262 73.6-80.1 3.41 1.31 64 High Fat Male Serum glucose, serum insulin
All LOD scores exceed the 5% chromosome-speciﬁc thresholds. QTL, quantitative trait loci; SNP, marker at QTL position; CI, conﬁdence interval in MB; a, additive
genotypic score; no. genes, number of genes in conﬁdence interval. Number in QTL name indicates chromosome number. Other QTL in interval phenotypes from
Cheverud et al. (2004a) and J. Kenney-Hunt, unpublished data.
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advanced intercross mice (Wustl:LG,SM-G34; N =1149) for ﬁne map-
ping QTL. Because the F34 population is a randomly mated advanced
intercross line (AIL) rather than a RI strain set, the sample size is
greatly increased, there are heterozygous individuals in the population,
and the population has accumulated more recombination across the
genome. These characteristics allow for examination of dominance,
epistasis, and for ﬁne-scale (,1 cM) mapping for liver fat phenotypes.
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